Terms: = Cervical cancer AND MUC16, CA125, CA-125
317 results:
1. cervical clear cell carcinoma: Case report and literature review.
Su D; Song X; Wu F; Fan S; Li M
Medicine (Baltimore); 2024 Mar; 103(13):e37449. PubMed ID: 38552088
[TBL] [Abstract] [Full Text] [Related]
2. Risk factors for pelvic and para-aortic lymph node metastasis in non-endometrioid endometrial cancer.
Sun Y; Wang Y; Cheng X; Wu W; Liu Q; Chen X; Ren F
Eur J Surg Oncol; 2024 Apr; 50(4):108260. PubMed ID: 38484492
[TBL] [Abstract] [Full Text] [Related]
3. Metastasis of cervical cancer indicated by elevation of serum ca125 produced by mediastinal lymph nodes: a case report.
Honda KI; Miyama M; Nishii Y; Tasaka R; Nakano Y; Umesaki N; Fukuda T; Ichimura T; Yasui T; Sumi T
J Med Case Rep; 2024 Feb; 18(1):112. PubMed ID: 38402387
[TBL] [Abstract] [Full Text] [Related]
4. Identifying tumor markers-stratified subtypes (ca-125/CA19-9/carcinoembryonic antigen) in cervical adenocarcinoma.
Zhang Z; Li Y; Wu Y; Bi R; Wu X; Ke G; Zhu J
Int J Biol Markers; 2023 Dec; 38(3-4):223-232. PubMed ID: 37933442
[TBL] [Abstract] [Full Text] [Related]
5. Intratumoral and peritumoral MRI radiomics nomogram for predicting parametrial invasion in patients with early-stage cervical adenocarcinoma and adenosquamous carcinoma.
Xiao ML; Fu L; Wei Y; Liu AE; Cheng JJ; Ma FH; Li HM; Li YA; Lin ZJ; Zhang GF; Qiang JW
Eur Radiol; 2024 Feb; 34(2):852-862. PubMed ID: 37610442
[TBL] [Abstract] [Full Text] [Related]
6. A nomogram prediction model for the TP53mut subtype in endometrial cancer based on preoperative noninvasive parameters.
Wang W; Li X; Gao Y; Zheng H; Gao M
BMC Cancer; 2023 Aug; 23(1):720. PubMed ID: 37528420
[TBL] [Abstract] [Full Text] [Related]
7. [Prognosis analysis of radical or modified radical hysterectomy and simple hysterectomy in patients with stage Ⅱ endometrial cancer].
Zhai ZY; Li H; Li LW; Shen ZH; Zhang XB; Wang ZQ; Wang JL
Zhonghua Fu Chan Ke Za Zhi; 2023 Jun; 58(6):442-450. PubMed ID: 37357603
[No Abstract] [Full Text] [Related]
8. Expression of
Ibrahim Jaber S; Qasim Dhumad B
Arch Razi Inst; 2022 Dec; 77(6):2125-2130. PubMed ID: 37274879
[TBL] [Abstract] [Full Text] [Related]
9. Serum expression of tumor marker CA242 in patients with different gynecological diseases.
Zhu J; Li H
Lab Med; 2023 Nov; 54(6):613-617. PubMed ID: 37035887
[TBL] [Abstract] [Full Text] [Related]
10. Highly expressed circ_0000285 from serum and cervical exfoliated cells as a novel biomarker for the diagnosis of early stage-cervical cancer.
Chen H; Tian X; Luan Y; Lu H
J Obstet Gynaecol; 2023 Dec; 43(1):2196344. PubMed ID: 37029728
[TBL] [Abstract] [Full Text] [Related]
11. Laparoscopic Management of Disseminated Peritoneal Leiomyomatosis.
Kriplani I; Kriplani A; Sharma S; Sodhi M; Jain N
J Minim Invasive Gynecol; 2023 Jun; 30(6):443-444. PubMed ID: 36934877
[TBL] [Abstract] [Full Text] [Related]
12. Value of TCT combined with HPV and ca125 in early cervical cancer screening in a medical examination population.
Xiao M; Zhang Z; Yu X; Fan Y; Chen X
Cell Mol Biol (Noisy-le-grand); 2022 Sep; 68(9):160-164. PubMed ID: 36905257
[TBL] [Abstract] [Full Text] [Related]
13. Current and emerging biomarkers in ovarian cancer diagnosis; ca125 and beyond.
Sharma T; Nisar S; Masoodi T; Macha MA; Uddin S; Akil AA; Pandita TK; Singh M; Bhat AA
Adv Protein Chem Struct Biol; 2023; 133():85-114. PubMed ID: 36707207
[TBL] [Abstract] [Full Text] [Related]
14. Long-Term Efficacy and Toxicity of Intensity-Modulated Radiotherapy in Bulky cervical cancer.
Wang Y; Lo TT; Wang L; Hsu ST; Hwang SF; Lu CH; Sun L
Int J Environ Res Public Health; 2023 Jan; 20(2):. PubMed ID: 36673916
[TBL] [Abstract] [Full Text] [Related]
15. Evaluation of HE4 as a prognostic biomarker in uterine cervical cancer
Dubey H; Ranjan A; Durai J; Khan MA; Lakshmy R; Khurana S; Gupta S; Meena J; Ray MD; Tanwar P; Chopra A; Tiwari S
Cancer Treat Res Commun; 2023; 34():100672. PubMed ID: 36525756
[TBL] [Abstract] [Full Text] [Related]
16. Changes of T Lymphocyte Subsets in Peripheral Blood of Patients with Intermediate and Advanced cervical cancer before and after Nimotuzumab Combined with Chemoradiotherapy.
Teng F; Cui G; Qian L; Zhao L
Int Arch Allergy Immunol; 2023; 184(1):85-97. PubMed ID: 36265457
[TBL] [Abstract] [Full Text] [Related]
17. Pathways to diagnosis of endometrial and ovarian cancer in the 45 and Up Study cohort.
Yap S; Vassallo A; Goldsbury D; O'Connell DL; Brand A; Emery J; DeFazio A; Canfell K; Steinberg J
Cancer Causes Control; 2023 Jan; 34(1):47-58. PubMed ID: 36209449
[TBL] [Abstract] [Full Text] [Related]
18. Laparoscopic Radical Hysterectomy Combined with Neoadjuvant Chemotherapy for cervical cancer Patients Effectively Improves Immune Function.
Liu M; Wang H; Du S; Li W; Xuan F; Zhao Y; Li N
Dis Markers; 2022; 2022():3611174. PubMed ID: 36157208
[TBL] [Abstract] [Full Text] [Related]
19. Xanthogranulomatous inflammation caused by K. pneumonia and nocardiosis mimicking a uterine tumor and invading the ureter and colon: A case report and review of the literature.
Shen TA; Hsu YH; Ding DC
Taiwan J Obstet Gynecol; 2022 Sep; 61(5):889-895. PubMed ID: 36088063
[TBL] [Abstract] [Full Text] [Related]
20. The value of HPV genotypes combined with clinical indicators in the classification of cervical squamous cell carcinoma and adenocarcinoma.
He Z; Chen R; Hu S; Zhang Y; Liu Y; Li C; Lv F; Xiao Z
BMC Cancer; 2022 Jul; 22(1):776. PubMed ID: 35840910
[TBL] [Abstract] [Full Text] [Related]
[Next]
